There is a reason
your eyes age,
we finally understand it
Your eyes lose specific lipids with age.
Standard supplements can’t replace them.
Vision Lipids™ can.
Why standard
supplements fall short
01
Not about intake
02
The pathway slows
03
Output falls short
Introducing
ELOVL™ Vision Lipids
The specialized lipids your eyes actually use
- Past the bottleneck, ready for action
- Doesn't depend on pathways that weaken with age
- Made for eye health, not general wellness
The world’s first VLC-PUFA supplement for aging eyes
Decades of research showed which lipids your eyes need
Recent studies confirmed they matter for aging vision
Today, you can finally get them in a softgel
In partnership with Epax®
Vision Lipids features EPAX® Evolve 05, the world’s first commercially available VLC-PUFA concentrate — developed through a decade of R&D and patented processing.
- Manufactured under pharma-grade quality systems
- No solvents, oxygen-free processing from sea to softgel
- Fish oil processed and concentrated in Norway since 1838
Reserve your spot.
Get 10% off at launch.
Founding members who join today get 10% off Vision Lipids at launch.
Your launch discount will apply automatically to your first order, and it stacks with any subscription you choose.
No cost to join. Your 10% discount will be applied automatically when we launch. No code needed.
Offer valid for first-time orders. Stackable with any subscription.
What’s happening inside your eyes
01 Constant demand Your retina never rests — and that makes it vulnerable.
Your retina never rests. It processes light continuously — and that constant work consumes more oxygen per gram than almost any other tissue in your body. That metabolic intensity makes it uniquely vulnerable to damage over time.
VLC-PUFAs — very long-chain polyunsaturated fatty acids — are the structural fats that protect photoreceptor membranes under that constant load. A lipid is simply the scientific word for a fat; VLC-PUFAs are a specialized type: longer, rarer, and built specifically for sensitive tissues — in particular, the retina. Less fuel, more armor. The material keeping the engine from burning itself out.
02 Declining production Your body makes these lipids — but less with age.
03 Conversion bottleneck This is why standard supplements fall short
Standard omega-3 supplements give your body the raw ingredients it would normally convert into VLC-PUFAs. But that conversion requires ELOVL2 working.
When the enzyme goes quiet — as it does after 40 — those omega-3s have nowhere to go. It’s like delivering ingredients to a kitchen where the stove has been turned off.
This explains one of the most puzzling findings in eye health research: the landmark AREDS2 trial, one of the largest macular degeneration studies ever done, found no benefit from fish oil supplementation. The raw material was there. The enzyme to use it wasn’t.
ELOVL2 is part of a broader aging process
These lipid pathways are being studied across multiple tissues involved in aging.
The retina is where the science is most developed — which is why ELOVL Vision Lipids is focused there.
Brain & Cognition
VLC-PUFAs are present in neural tissue and are being studied for their role in signaling and brain function.
Skin & Barrier Function
Related lipids support skin structure and barrier integrity, with changes observed over time.
Cellular Aging
ELOVL2 activity is closely associated with biological aging at the cellular level.
Cardiovascular Health
Early research explores links between lipid pathways and metabolic and inflammatory processes.
Reproductive Health
These lipids are found in high concentrations in reproductive tissues and remain an active area of study.
Longevity Science
These pathways are being studied for their role in age-related cellular processes across the body.
Note: Research across these systems is still emerging. Vision Lipids is formulated specifically for eye health.
Launching 2026.
Reserve your spot.
Medical Disclaimer
The information on this page is for general educational purposes only and does not constitute medical advice. Vision Lipids is a dietary supplement, not a drug, and has not been evaluated or approved by the Food and Drug Administration to diagnose, treat, cure, or prevent any disease — including age-related macular degeneration or any other eye condition. Research referenced here was conducted primarily in laboratory and animal models; results in humans may differ. Descriptions of research on tissues other than the retina are provided for educational context only and do not constitute product claims. If you are experiencing vision changes or have concerns about your health, consult a licensed healthcare professional. Do not delay or discontinue medical care based on anything on this page. Individual results from dietary supplementation vary.